What question did this study set out to answer?

The study aims to characterize the clinical significance of MYD88 L265P mutation in Waldenstrom macroglobulinemia.

March 27, 2013BloodOpen Access

MYD88 L265P mutation in Waldenstrom macroglobulinemia

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial analyzes the MYD88 L265P mutation in Waldenstrom macroglobulinemia, suggesting new insights into treatment strategies.

The study aims to characterize the clinical significance of MYD88 L265P mutation in Waldenstrom macroglobulinemia.
Analyzed MYD88 mutation in exon 5 in 67 Waldenstrom macroglobulinemia patients
Examined clinical features, immunophenotypic markers, cytogenetic data, and SNP array data
Utilized whole exome sequencing to detect MYD88 mutation frequency
MYD88 L265P mutation found in 79% of patients with WM
91% of patients showed alteration of MYD88 locus
Patients without MYD88 mutation exhibited unique characteristics such as female predominance and splenomegaly

Poulain et al. (2013) studied this question.

View Full Paper

Ask AI

Bookmark